AGP Picks
View all

Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

Press releases published on October 21, 2026

NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
Science News unveils its list of 10 scientists making an impact on our world
Atalan to Present New Research on Measuring AI’s Real-World Impact and Predicting Nurse Turnover
Healthcare’s Financial Leaders Pledge Unprecedented Collaboration to Address America’s Healthcare Affordability Crisis
Organic & Natural Health Association Shares 5 Ways Americans Can Protect Their Health as Insurance Costs Rise
P-Protect Introduces P-Protect Patch - A New Patch-Based Option for Men’s Prostate Wellness
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
TaiMed Biologics Reports IDWeek 2026 Data Highlighting TMB-365 and Its Potential Across Long-Acting HIV Combinations
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
10X Health Launches Metabolism Genetic Test
Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
IMUNON Announces Strategic Sale of ThermoDox®
Onicor Appoints Antifungal Pioneer Piet De Doncker, PhD, as CEO to Advance Personalized Treatment for Fungal Nail Infections
Santa Ana Bio to Present Preclinical Data on SAB05, a CD40-Targeted Glucocorticoid Antibody-Drug Conjugate, at ACR Convergence 2026
Inspire and PatientPartner Announce Partnership to Expand Patient Mentorship and Community Support
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
Dr. Falk Pharma and Renexxion Reach Alignment with FDA and EMA on Phase 3 Program for Naronapride in Gastroparesis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Missouri Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.